[This review was originally posted at the Nieman Journalism Lab Purchase Retin A, on July 29, 2011.]

Debating the Times' paywall and design: In its quarterly earnings call late last week, the New York Times gave the clearest picture yet of how its new online pay plan is working. As usual, it turned out to be something of a Rorschach test: BNET's Erik Sherman called the numbers evidence that the paywall isn't protecting the Times' print subscriptions, as it was intended to. On the other hand, the Columbia Journalism Review's Ryan Chittum argued that the Times' big digital subscription figure (224, Retin A images,000) "proves that, contra the naysayers, readers will pay good money for quality news." The Times' paywall adds an important digital revenue stream, he said, Online Retin A without a prescription, while also letting in enough casual readers to keep the value of digital advertising up.

The most thorough defense of the Times, though, came from New York magazine's Seth Mnookin: "The Times has taken a do-or-die stand for hard-core, boots-on-the-ground journalism, for earnest civic purpose, low dose Retin A, for the primacy of content creators over aggregators, and has brought itself back from the precipice."BNET's Jim Edwards said it's premature for Mnookin to say the Times is back, but Reuters' Felix Salmon, a former Times paywall skeptic, Where can i order Retin A without prescription,  agreed with Mnookin that the paywall is working, saying he's glad the Times has shown a porous paywall can work.

The other Times-related item is firmly in the hypothetical realm, but it generated at least as much conversation as the real-world pay plan. Last week, web designer Andy Rutledge critiqued the Times' online design and proposed his own version, emphasizing headlines, time stamps, authors, and separating news from opinion, Purchase Retin A.

The response wasn't particularly positive. The redesign was generally trashed on Twitter, Retin A natural, with a typical sentiment expressed by 10,000 Words' Lauren Rabaino: "It’s hard to take seriously a design that completely ignores the constraints of a typical newspaper." One of the most comprehensive responses came from Guardian developer Martin Belam, who pointed out things like faces, article summaries, Retin A overnight, and points of social connection that Rutledge was missing.

The Lab's Joshua Benton argued that Rutledge's redesign doesn't acknowledge that "the problems of large-scale information architecture for news sites are really hard problems." Meanwhile, Belgian developer Stijn Debrouwere went the other direction, asking for more unrealistic mockups like this one to help us brainstorm what news sites could look like. GigaOM's Mathew Ingram said the problem with the Times' site is that it's designed as if readers are interested in everything the paper produces, which is almost never the case, is Retin A addictive. And Paul Scrivens said both Rutledge and the Times should look outside the news industry Purchase Retin A, for design cues.

—

Google+ growing pains: Google+ continues to grow at a ridiculous pace — far faster than either Facebook or Twitter, as Idealab's Bill Gross pointed out — and as Simon Dumenco of Ad Age argued, the platform represents a social media do-over for a lot of users. It's still generating dissent, Australia, uk, us, usa, though, with much of it stemming from Google+'s policy toward business pages. As Google's Christian Oestlien wrote late last week, the company is working on a business profile template that will be up in the next few months, but they're deleting business pages (including news organization pages) in the meantime.

A few companies will get trial pages before they're available to everyone, Retin A steet value, and others have found workarounds — the tech blog Mashable managed to keep all its followers by simply changing its page name to the name of its CEO, Pete Cashmore. That got other members of the tech press worked up, including Search Engine Land's Danny Sullivan, who urged Google to restore the deleted pages and let businesses create pages normally, Purchase Retin A. TechCrunch's MG Siegler said Google is essentially creating its own version of Twitter's Suggested User List, and Mathew Ingram of GigaOM made the case for why this is a big deal. Retin A from mexico, Elsewhere in the world of Google+, Mathew Ingram wrote about the issues it's dealing with regarding anonymity, and the Atlantic's Alexis Madrigal is experimenting with a daily news roundup on his personal page there. The Next Web's Martin Bryant examined Google+'s usefulness as a news tool, concluding that while it has potential, it needs a bigger, Retin A pictures, broader user base to start to really challenge Twitter and Facebook.

—

The end of media moguls?: The News Corp. Purchase Retin A, phone hacking scandal shifted down a gear this week, but there were still a few developments to report. The News of the World hacking victims also reportedly included the mother of an 8-year-old murder victim, and two former employees testified that they had told James Murdoch that the hacking was widespread, Retin A wiki, contradicting what Murdoch had told Parliament last week. Other News Corp. veterans challenged the picture Rupert Murdoch painted of himself as a largely hands-off newspaper boss.

The New York Times' David Carr wrote that James Murdoch is done, and that Rupert has finally been revealed as vulnerable. CUNY j-prof Jeff Jarvis was more emphatic, calling Murdoch the last media mogul: "The mogul is extinct, Purchase Retin A. The kind of big media institution he built will follow him, Retin A price. Lovely chaos will follow. It’s called democracy." The Washington Post's Erik Wemple took a quick look at what a post-Murdoch world might look like.

A couple of other News Corp.-related avenues to chase down: Dean Starkman of the Columbia Journalism Review argued that a scandal like News of the World's won't happen in the U.S., and News Corp.'s newest property, Retin A blogs, the tablet publication The Daily, appears to be floundering, according to a New York Observer feature, though a new version was released last week.

—

Reading roundup Purchase Retin A, : There wasn't a whole lot to take in this week, but here's a quick sampling:

— The FCC is releasing a series of studies on media ownership, one of the newest of which suggested that media cross-ownership (ownership of multiple media outlets within a single market) doesn't hurt local news, and may actually help it.

— Wisconsin j-prof Stephen Ward made a thoughtful case for redefining objectivity in the digital age.

— Particularly for the Twitter skeptics and writing teachers out there, Retin A brand name, Poynter's Mallary Jean Tenore put together a great post outlining the ways Twitter has made her a better writer.

— Finally, I've been trying to cover this piecemeal discussion here, but the AP's Jonathan Stray did a much better job of summarizing the recent conversation about the changing structure of news stories with a fantastic reading list. Now that you're done with this link-fest, be sure to give that one a look-through, too.

Similar posts: Synthroid Dosage. Cipro For Sale. Cipro Dosage. Cheap Zoloft. Generic Bactrim. Real brand Cipro online.
Trackbacks from: Purchase Retin A. Purchase Retin A. Purchase Retin A. Canada, mexico, india. Retin A without prescription. No prescription Retin A online.

[This review was originally posted at the Nieman Journalism Lab Cephalexin Cost, on July 22, 2011.]

Murdoch's damage-control efforts: As News Corp.'s hacking scandal continues to metastasize, it can be difficult to keep up with all the background, angles, and implications. The best one-stop source is Mallary Jean Tenore's explainer for Poynter, and I'll try to update you on all the developments of the past week.

The big event came on Tuesday, when Rupert Murdoch, his son James, Order Cephalexin online overnight delivery no prescription, and his former British chief Rebekah Brooks answered questions from Parliament about the scandal. The Guardian gave a great, quick rundown of what happened there, and the general theme was Murdoch's professed lack of knowledge of the illegal activity at his News of the World tabloid. That's what the Daily Beast's Howard Kurtz took away from it, and Slate's Jack Shafer noted that while the Murdochs kept playing the victim card, they wouldn't say who exactly victimized them, where can i buy Cephalexin online. That was all part of a calculated PR and legal defense, outlined by Nick Davies of the Guardian, Cephalexin Cost.

While many people obviously found the idea of a blissfully ignorant Murdoch family hard to believe, Reuters' Felix Salmon said their strategy was effective enough. Still, the scandal has led to some probing questions about the culture that the Murdochs have created at News Corp. The New York Times' David Carr documented a history of illegal and anticompetitive behavior in the company's American arm, About Cephalexin, and Poynter's Steve Myers called this a corporate corruption story in the Enron vein. In the Guardian, NYU prof Jay Rosen asserted that "News Corp is not a news company at all, but a global media empire that employs its newspapers – and in the US, Fox News – as a lobbying arm."

The episode also has implications beyond News Corp. itself: Media consultant Alan Mutter said it weakens the already damaged trust Cephalexin Cost, Americans have in the media, and the New York Times reported that media consolidation opponents are hoping it provides an opportunity to re-examine the problems in modern media ownership. Here at the Lab, Ken Doctor wrote about why media concentration should be a concern in the U.S., Cephalexin no rx, and the Online Journalism Review's Robert Niles said that's why he's rooting for News Corp. to fail.

So what's next for News Corp.. The long-term future of both Rupert and James Murdoch at the company was in question this week, though Rupert assured Parliament he'd be sticking around. Felix Salmon speculated that the whole company could be in play if things go sour, and CUNY j-prof Jeff Jarvis looked at one possible scenario resulting in a News Corp, Cephalexin Cost. Cephalexin from canadian pharmacy, news and publishing sell-off. Ken Doctor, meanwhile, said News Corp. might end up becoming a more American company as a result of the scandal.

Murdoch still has his defenders, though the most vocal of them at this point (aside from the New York Observer) are media outlets owned by Murdoch himself. Perhaps the most full-throated of those defenses came in the Wall Street Journal, ordering Cephalexin online, which ran numerous opinion pieces, including one equating the hacking with WikiLeaks and an editorial lashing out at Murdoch's critics. PaidContent's Staci Kramer said the Journal would have been better off Cephalexin Cost, spiking the editorial, and the Columbia Journalism Review's Ryan Chittum argued that the Journal's characterization of investigative reporting as ideologically motivated tells us a lot about the "intellectual bankruptcy" of the Journal's editorial page itself.

Even before the editorial, the New York Times' Joe Nocera said the whole paper had been "Fox-ified" — turned shallow and ideological — by Murdoch's influence. Ryan Chittum countered that the paper has declined under Murdoch, Is Cephalexin safe, but it's far from hopeless, and Journal staffers also defended themselves against the "Foxification" charge. Meanwhile, a Pew study found that the actual Fox News Channel is covering the scandal far less than its rivals, and the Guardian continued to earn praise for its coverage of the story, with editor Alan Rusbridger describing in Newsweek how they did it.

—

Should nonprofit news be more objective?: Pew's Project for Excellence in Journalism released a study this week examining the growing group of nonprofit news organizations, buy cheap Cephalexin, evaluating them specifically for ideological nature and transparency. The study found that of the several dozen new nonprofit sites covering state and national news it looked at, about half are clearly ideological, Cephalexin Cost. Poynter's Rick Edmonds wrote a good, quick summary, noting in particular that several of the most ideological sites offered no clue to their orientation in their names, and that the most productive sites tended to be the least ideological ones. What is Cephalexin, The Lab's Joshua Benton inferred the study's implicit message — the new nonprofit news isn't objective, can't be fully trusted, and especially not to replace newspapers. Benton pushed back against those conclusions, arguing that the new sites aren't meant to replace newspapers, and that their lack of objectivity doesn't keep them from being useful to society.

The Columbia Journalism Review's Greg Marx was a bit more pointed in his response, where can i find Cephalexin online, picking apart some of its examples and particularly the implicit conclusion that Benton identified: "The PEJ report is suffused throughout with a sense that it’s the obligation of the new non-profits to reincarnate as best they can the status quo ante ... But it’s worth remembering that, in many times and many places, the status quo ante wasn’t all that good."

—

Scribd to see if news will Float: Over the past year or so, we've seen several new attempts to charge for news online by aggregating news from a variety of news outlets, with services like Ongo and News.me. Cephalexin Cost, This week, the document-sharing site Scribd launched its own entry into that space with Float, a mobile reading app that allows users to read subscribers from a variety of sources — what it calls a "Netflix for news." Float launched a free version this week, but will introduce its paid subscription service this fall. Cephalexin duration, Float has a social media-oriented aspect and an Instapaper-like reading list, but as TechCrunch described, its main feature is its ability to present any type of page, from books to blogs to news articles, in the same uniform, easily browseable format. GigaOM's Colleen Taylor found the fluid presentation remarkable, comprar en línea Cephalexin, comprar Cephalexin baratos, but wondered if Float could get a critical mass of news sites to make it worth paying for. PaidContent's David Kaplan said that Float works like a hybrid between Instapaper and Pulse, but that it could try to sell publishers on the idea of picking up browsing readers, rather than devoted subscribers.

Meanwhile, Buy Cephalexin without prescription, another traditional media outlet moved forward with an online paid-content strategy: Time introduced a plan that allows readers to subscribe to a bundle of the magazine's print publication, mobile/tablet apps, and web version. As All Things D's Peter Kafka reported, that also includes shutting off magazine articles on the web from nonsubscribers, though most of the web content should remain free. David Kaplan of paidContent said while it's always an uphill battle to get readers to pay for news online, magazine publishers are aided by the fact that they're becoming more unified in charging for their tablet editions, Cephalexin Cost.

—

Big Google+ possibilities: As Google+ continues to grow, tech writers continue to think bigger about what it could end up being. O'Reilly Radar's Edd Dumbill said Google+ could be the program that connects people across the entirety of the web, just search does for information. "Google+ is the rapidly growing seed of a web-wide social backbone, Cephalexin price, coupon, and the catalyst for the ultimate uniting of the social graph," he wrote. Tim Carmody of Wired argued that Google+ is also part of the ramp-up to the coming "Cloud Wars" between Google and Microsoft.

We're starting to see more possibilities for Google+ and journalism, too: Mashable provided a list of ways journalists can use the service, Cephalexin brand name, and 10,000 Words put together a guide to Google+ and breaking news. Poynter's Jeff Sonderman said Google+ can teach news organizations some lessons Cephalexin Cost, about innovation and developing new products. Unfortunately, Google is removing many company/brand accounts from the service right now, including the innovative BreakingNews and KOMU-TV accounts.

—

Reading roundup: Here's what else we talked about this week:

— The Columbia Journalism published online its feature on the Journal Register Co. from earlier this summer, while the Lab's Martin Langeveld gave some smart analysis on what Alden Global Capital's purchase of the newspaper chain last week might mean for the company's media consolidation plans.

— Yesterday would have marked the 100th birthday of our best-known media theorist, Marshall McLuhan, and the Lab celebrated with some fantastic essays on his legacy by Megan Garber and Maria Bustillos. At the Guardian, Douglas Coupland wrote about why McLuhan still matters, Cephalexin Cost.

— NYU j-prof Jay Rosen and author Nicholas Carr finished their debate over whether the Internet has been good for journalism, and Rosen also expounded on five key works to understanding journalism in the Internet age.

— Three great pieces to read now ... or later ... whenever: Anil Dash on how to make sure the people using your website treat each other with decency, Paul Ford on the way Facebook defies the journalistic impulse to craft simple narratives, and Scott Rosenberg with a book (available free via PDF) on the new ethics of online journalism.

Similar posts: Cipro Over The Counter. Purchase Flagyl. Buy Bactrim No Prescription. About Glucophage. Where can i order Glucophage without prescription. Cipro brand name.
Trackbacks from: Cephalexin Cost. Cephalexin Cost. Cephalexin Cost. Cephalexin reviews. Buy Cephalexin no prescription. Cephalexin pics.

[This review was originally posted at the Nieman Journalism Lab Purchase Glucophage, on July 18, 2011.]

News Corp.'s scandal keeps growing: Rupert Murdoch might have hoped News Corp.'s phone hacking scandal would die down when he closed the British tabloid News of the World last week, but it only served to fuel the issue's explosion. This past week, the scandal's collateral damage spread to News Corp.'s proposed takeover of the British broadcaster BSkyB: Faced with increasing pressure from the British government and the revelation that News Corp. journalists tried to get private records of former Prime Minister Gordon Brown, News Corp. dropped the BSkyB bid, which had been a huge part of the company's U.K. strategy. Buy no prescription Glucophage online, Plenty of other problems are cropping up for News Corp., too. The top lawyer for its U.K, Purchase Glucophage. newspaper branch, News International, quit. The company's stock lost $7 billion in four business days at one point. A pre-existing U.S. shareholders' suit expanded to cover the hacking scandal, is Glucophage addictive. The Murdochs have to testify before British Parliament Purchase Glucophage, this week about the scandal, and the FBI started investigating U.S.-related aspects of the issue. That's all in addition to the ongoing problems News Corp. faces, as detailed by Poynter's Rick Edmonds.

The scandal has led quite a few writers to criticize the culture that Murdoch has created at News Corp. Capital New York's Tom McGeveran and Reuters' John Lloyd railed on Murdoch and News Corp.'s character, Carl Bernstein called this Murdoch's Watergate, Canada, mexico, india, and the Observer's editorial board called for systemic reforms in Britain so Murdoch's influence can never be so strong. Members of the Bancroft family said they wouldn't have sold the Wall Street Journal to Murdoch in 2007 if they'd have known the hacking was going on, Purchase Glucophage.

On the other hand, the New York Times pointed out that sleazy British tabloid tactics are hardly limited to Murdoch, and media critic Howard Kurtz noted that they're very much alive in the U.S. mainstream press, too. New York Times columnist Roger Cohen defended Murdoch, saying he's been good for journalism on the whole, purchase Glucophage online, and Gawker's John Cook defended those tabloid reporting tactics. Meanwhile, j-prof Jeff Jarvis and the Telegraph's Toby Harnden urged the British government not to respond by enacting more regulation. Purchase Glucophage, News Corp.'s retreat might not stop with News of the World and BSkyB. Murdoch biographer Michael Wolff and others have reported that the company's execs are debating whether to get out of Britain's newspaper business entirely, and several observers chimed in to say that might actually make a good deal of business sense. Media analyst Ken Doctor said News International is losing steam, After Glucophage, and the Financial Times' John Gapper said newspapers are becoming far more trouble than they're worth to Murdoch.

Not only that, but the New Yorker's John Cassidy said dropping his U.K. newspapers could let Murdoch revive his BSkyB bid, and Jeff Jarvis speculated that when Murdoch chooses between the power that the papers give him and the money saved by getting rid of them, he'll choose the money. In an interview with the Wall Street Journal, Murdoch called the rumors of a newspaper sell-off "rubbish."

But just because News of the World and News International may be dead and dying, that doesn't mean newspapers as a whole are, argued David Carr of the New York Times, Purchase Glucophage. As he noted, it was the Guardian's dogged reporting that finally broke this story open. Murdoch "prefers his crusades to be built on chronic ridicule and bombast, Glucophage used for. But as The Guardian has shown, the steady accretion of fact — an exercise Mr. Murdoch has historically regarded as bland and elitist — can have a profound effect," Carr wrote. The Atlantic also had praise for the Guardian, and Poynter's Mallary Jean Tenore interviewed one of its editors about the lonely journey of covering the phone hacking story.

—

HuffPo aggregation under the microscope Purchase Glucophage, : A lively discussion about the rights and wrongs of aggregation developed last week out of a column by Ad Age media critic Simon Dumenco, who complained that the Huffington Post had extensively summarized one of his posts, buried the link to the original, and — contrary to Arianna Huffington's argument that her site benefits those they aggregate by sending them readers — gave him just 57 page views. Buy Glucophage without a prescription, The Huffington Post responded by apologizing and suspending the article's writer. HuffPo business editor Peter Goodman told Adweek the piece was a fully formed article when it should have been a simple introduction and a link, but Dumenco responded to the apology by arguing that the writer did nothing out of the ordinary — this is just how HuffPo tells its writers to do it.

Dumenco's point was echoed by several others: The Awl's Choire Sicha said the suspended writer was doing what she was taught, Gawker's Ryan Tate, drawing on a revealing quote from a former HuffPo writer, made the same point: "This is pretty ridiculous, given HuffPo's systematic, Glucophage dosage, officially-sanctioned approach to rewriting too much of people's news articles." British journalist Kevin Anderson called HuffPo's summary-heavy aggregation "a pretty cynical strategy," and paidContent's Staci Kramer said HuffPo needs to respect its sources, rather than treating a link as a favor.

Gabe Rivera, whose news site, Techmeme, Where can i order Glucophage without prescription, was compared to HuffPo favorably by Dumenco, looked for terms to distinguish what his site does from what HuffPo does. Poynter's Julie Moos said some measure of originality will always make for better journalism and a better business model than heavy aggregation, and ZDNet's Tom Foremski pined for the old blogging mentality whose goal was to add value, Purchase Glucophage. In a short podcast, author Steven Rosenbaum said this is a logical time to step back and evaluate exactly what constitutes ethical aggregation.

There were a few dissenters, though: GigaOM's Mathew Ingram and Slate's Jack Shafer both argued that the type of aggregation that HuffPo does has been around for ages in traditional media (especially in Britain, according to Forbes' Tim Worstall). In fact, Glucophage coupon, Shafer said, news orgs could learn a something valuable from the Huffington Post: "That a huge, previously ignored readership out there wants its news hot, quick, and tight."

—

Comparing Google+, Facebook, Cheap Glucophage, and Twitter: It's been just about three weeks since Google+ launched, and Google's new social network is growing like a weed, with estimates of as many as 10 million users so far. (Its number of active users may soon be approaching Twitter's figures.) Google+ news has dominated Twitter, and Google's also working on integrating it with Gmail. Purchase Glucophage, With Plus' incredible growth, tech observers have been going back and forth about what social network Google+ is disrupting most. PCWorld's Megan Geuss wondered whether Google+ and Facebook can coexist, and PC Magazine's John Dvorak posited that all the excitement about Google+ is more or less just pent-up frustration with Facebook. The New York Times' David Pogue and Technology Review's Paul Boutin both compared Google+ favorably to Facebook, largely because of its superior privacy controls (though GigaOM's Mathew Ingram pointed out that it may not be a privacy improvement for some people).

Meanwhile, Search Engine Land's Danny Sullivan said Google+ is more comparable to Twitter, Glucophage natural, then went ahead and made a thorough, smart comparison between the two. The Atlantic's Alexis Madrigal said Google+ might end up being more conversational than Twitter, which he called more of a call-and-response: Google+ "won't be as good at connecting people to information or each other quickly, but it might be better at longer form discussions and whatever we call the process by which people pull reasoned thoughts from their networks into public discourse." Hutch Carpenter said Google+ resembles both Facebook and Twitter, and Computer World's Mike Elgan wrote that it'll disrupt just about everything.

Still, Google+ has its limits: ReadWriteWeb's Marshall Kirkpatrick explained why he'd never move his personal blog there as some are doing, and Instapaper's Marco Arment and the Guardian's Dan Gillmor both urged readers to keep a space for their own online identity outside of spaces like Google+ or Facebook, Purchase Glucophage. For journalists feeling out Google+, Meranda Watling of 10, Glucophage from canada,000 Words put together a preliminary guide.

—

Reading roundup: Here's what else people were talking about this past week:

— The newspaper chain MediaNews made a distinctive play for the tablet news market last week, announcing the launch of TapIn, a location-based news app made specifically for tablets. It'll start in the Bay Area in partnership with the San Jose Mercury News. Ken Doctor, Jeff Sonderman, Glucophage overnight, and Mathew Ingram all wrote about what makes it worth watching.

— The Economist continued running pieces all week in its series on the future of the news industry. You can check out several writers'reasons for optimism or read the opening statements in an ongoing debate between NYU's Jay Rosen and author Nicholas Carr about whether the Internet has been good for journalism.

— Boston Globe developer Andy Boyle made his pitch for young journalists to go into web development, or as he put it, "learn to make the internets."

— Poynter's Jeff Sonderman put together two great social media how-to's for journalists: One on verifying information on social media, and the other on strategies for engagement on Facebook.

— Finally, NYU's Clay Shirky gave us another thoughtful essay on the unbundling of news and why the news ecosystem needs to be chaotic right now. In the end, though, here's what he believes news should be: "News has to be subsidized because society’s truth-tellers can’t be supported by what their work would fetch on the open market"; "news has to be cheap because cheap is where the opportunity is right now"; and "news has to be free, because it has to spread.".

Similar posts: Zoloft No Rx. Bactrim For Sale. Glucophage Price. Tramadol coupon. Glucophage for sale. Cephalexin reviews.
Trackbacks from: Purchase Glucophage. Purchase Glucophage. Purchase Glucophage. Glucophage dose. Buying Glucophage online over the counter. Rx free Glucophage.

[This review was originally posted at the Nieman Journalism Lab Flagyl No Rx, on July 8, 2011.]

Google's biggest social effort yet: This is a two-week edition of This Week in Review, so most of our news comes from last week, rather than this week. The biggest of those stories was the launch of Google+, Google's latest and most substantial foray into the social media landscape. TechCrunch had one of the first and best explanations of what Google+ is all about, and Wired's Steven Levy wrote the most comprehensive account of the thinking at Google behind Plus: It's the product of a fundamental philosophical shift from the web as information to the web as people.

Of course, the force to be reckoned with in any big social media venture is Facebook, and even though Google told Search Engine Land it's not made to be a Facebook competitor, Flagyl pics, Google+ was seen by many (including the New York Times) as Google's most ambitious attempt yet to take on Facebook. The design looks a lot like Facebook, and pages for businesses (like Facebook's Fan Pages) are on their way.

Longtime tech blogger Dave Winer was unimpressed at the effort to challenge Facebook, and Om Malik of GigaOM said Facebook has nothing to be afraid of in Google+, though All Facebook's Nick O'Neill said Google+'s ubiquity across the web should present a threat to Facebook, Flagyl No Rx.

But the biggest contrast people drew between Google+ and Facebook was the more intuitive privacy controls built into its Circles feature. Ex-Salon editor Scott Rosenberg wrote a particularly thoughtful post arguing that Google+ more accurately reflects social life than Facebook: "In truth, Facebook started out with an oversimplified conception of social life, Order Flagyl online overnight delivery no prescription, modeled on the artificial hothouse community of a college campus, and it has never succeeded in providing a usable or convenient method for dividing or organizing your life into its different contexts." His thought was echoed by j-prof Jeremy Littau (in two posts) and the Guardian's Dan Gillmor.

Google's other ventures into social media — Buzz, Wave, Orkut — have fallen flat, so it's somewhat surprising to see that the initial reviews for Google+ were generally positive. Among those enamored with it were TechCrunch's MG Siegler, ReadWriteWeb's Marshall Kirkpatrick, Flagyl schedule, social media guru Robert Scoble, and the Huffington Post's Craig Kanalley (though he wondered about Google's timing). It quickly began sending TechCrunch loads of traffic Flagyl No Rx, , and social media marketer Chris Brogan brainstormed 50 ways Google+ could influence the rest of the web.

At the same time, there was some skepticism about its Circles function: TechCrunch's Siegler wondered whether people would use it as intended, and ReadWriteWeb's Sarah Perez said they might not be equipped to handle complicated, changing relationships. Flagyl over the counter, GigaOM's Mathew Ingram, meanwhile, said Circles look great, but they aren't going to be much use until there's a critical mass of people to put in them.

—

Google+ and the news: This being a journalism blog, we're most interested in Google+ for what it means for news. As Poynter's Jeff Sonderman pointed out, the aspect of Google+ that seems to have the most potential is its Sparks feature, Flagyl samples, which allows users to collect recommended news around a specific term or phrase. Former New York Times reporter Jennifer 8, Flagyl No Rx. Lee said Sparks could fill a valuable niche for news organizations in between Facebook and Twitter — sort of a more customizable, less awkward RSS. The University of Missouri’s KOMU-TV has already used it in a live broadcast, and Breaking News’ Cory Bergman gave a few valuable lessons from that organization’s first week on Google+.

CUNY j-prof Jeff Jarvis gave his thoughts on a few potential uses for news: It could be very useful for collaboration and promotion, Flagyl alternatives, but not so much for live coverage. Journalism.co.uk's Sarah Marshall listed several of the same uses, plus interviewing and "as a Facebook for your tweeps." Sonderman suggested a few changes to Google+ to make it even more news-friendly, including allowing news org pages and improving the Sparks search and filtering. Flagyl No Rx, Still, he saw it as a valuable addition to the online news consumption landscape: "It’s a serendipity engine, and if executed well it could make Google+ an addictive source of news discovery."

A bit of Google+-related miscellany before we move on: Social media marketer Christopher Penn gave some tips on measuring Google+, author Neil Strauss condemned the growing culture of Facebook "Likes" (and now Google +1s), and GigaOM's Mathew Ingram offered a rebuttal.

—

Murdoch kills News of the World: In one of the most surprising media-related moves of the year, Rupert Murdoch's News Corp. suddenly shut down one of its most prominent properties, the 168-year-old British tabloid News of the World, buy Flagyl online no prescription, on Thursday. The decision stemmed from a long-running scandal involving NotW investigators who illegally hacked into the phones of celebrities. This week, the Guardian reported that the hacking extended to the voicemail of a murdered 13-year-old girl and possibly the families of dead soldiers, and that the paper's editor, Rebekah Brooks (now the head of News Corp. in Britain) was informed of some of the hacking, Flagyl No Rx. Buy generic Flagyl, Facing an advertising boycott and Parliamentary opposition, Murdoch's son, James, announced News of the World will close this weekend. (The Guardian has the definitive blow-by-blow of Thursday's events.) It was a desperate move, and as the New York Times, paidContent, and many on Twitter noted, order Flagyl from mexican pharmacy, it was almost certainly an attempt to keep the scandal's collateral damage away from Murdoch's proposed BSkyB merger, which was put on hold and possible in jeopardy this week.

Though the closing left hundreds of suddenly out-of-work employees, it may prove less damaging in the big picture for News Corp. than you might expect. Flagyl No Rx, NotW only published on Sundays, and it's widely suspected that its sister tabloid, the Sun, will simply expand to include a Sunday edition to cover for its absence. As one Guardian editor stated, Real brand Flagyl online, the move may simply allow News Corp. to streamline its operation and save cash, and Poynter’s Rick Edmonds called it a smart business move. (Its stock actually went up after the announcement.)

There's plenty that has yet to play out: The Guardian pointed out how evasive James Murdoch's closing letter was, and Brooks, the one that many thought would take the fall for the scandal, is still around. And the investigation is ongoing, with more arrests being made today, fast shipping Flagyl. According to the New Yorker's Ken Auletta and CUNY's Jeff Jarvis, though, the buck stops with Rupert himself and the culture he created.

—

Making journalism easier on Twitter: Twitter has been reaching out to journalists for quite some time now through a media blog, but last week it took things a step further and launched Twitter for Newsrooms, a journalist's guide to using Twitter, with tips on reporting, making conversation, and promoting content, Flagyl No Rx. The Lab's Justin Ellis gave a quick glimpse into the rationale behind the project.

A few people were skeptical: TechCrunch's Alexia Tsotsis suspected that Twitter's preaching to the choir, arguing that for the journalists who come across Twitter for Newsrooms, Flagyl photos, Twitter already is a newsroom. The Journal Register's Steve Buttry called it "more promotional than helpful," and suggested some other Twitter primers for journalists. Ad Age's Matthew Creamer added a tongue-in-cheek guide to releasing your anger on Twitter. Flagyl No Rx, Meanwhile, the Lab's Megan Garber reported on the ideas of NPR and Andy Carvin for improving Twitter's functionality for reporting, including a kind of real-time influence and credibility score for Twitter sources, and a journalism-oriented meme-tracking tool for developing stories.

—

Mobile media and tablet users, profiled: There were several studies released in the past two weeks that are worth noting, starting with Pew's report on e-reader and tablet users. Pew found that e-reader ownership is booming, Flagyl use, having doubled in six months. The Knight Digital Media Center's Amy Gahran reasoned that e-readers are ahead of tablets right now primarily because they're so much cheaper, and offered ideas for news organizations to take advantage of the explosion of e-reader users.

Three other studies related to tablets and mobile media: One study found that a third of tablet users said it's leading them to read print newspapers and magazines less often; another showed that people are reading more on digital media than we think, and mostly in browsers; and a third gave us more evidence that games are still king among mobile apps.

—

Reading roundup: Bunches of good stuff to look through from the past two weeks, Flagyl No Rx. I'll go through it quickly:

— Turns out the "digital first" move announced last month by the Guardian also includes the closing of the international editions of the Guardian and Observer. Flagyl for sale, Jeff Jarvis explained what digital first means, but Suw Charman-Anderson questioned the wisdom the Guardian's strategy. The Lab's Ken Doctor analyzed the economics of the Guardian's situation, as well as the Mail and the BBC's.

— This week in AOL/Huffington Post news: Business Insider revealed some leaked lackluster traffic numbers for Patch sites, and reported that Patch is undergoing a HuffPo-ization. That prompted Judy Sims and Slate's Jack Shafer Flagyl No Rx, to be the latest to rip into Patch's business model, and Shafer followed up to address rebuttals about non-Patch hyperlocal news.

— Google+ was the only interesting Google-related news over the past two weeks: The Lab's Megan Garber wrote about Google's bid to transform mobile ads, potential new directions for Google News, online buy Flagyl without a prescription, and Google highlighting individual authors in search returns. The New York Times' Virginia Heffernan also wrote on Google's ongoing war on "nonsense" content.

— A couple of paywall notes: The Times of London reported that it has 100,000 subscribers a year after its paywall went up, and Dorian Benkoil said the New York Times' plan is working well, the Lab's Megan Garber wrote about the Times adding a "share your access" offer to print subscribers.

— Three practical posts for journalists: Poynter's Jeff Sonderman has tips for successful news aggregation and personalized news delivery, and British j-prof Paul Bradshaw reported on his experience running his blog through a Facebook Page for a month.

— And three bigger-picture pieces to think on: Wetpaint's Ben Elowitz on the shrinking of the non-Facebook web, former Guardian digital editor Emily Bell on the U.S.' place within the global media ecosystem, and the Economist on the role of news organizations in a citizen-driven media world.

Similar posts: Purchase Cipro. Diflucan No Rx. Buy Lipitor No Prescription. Retin A samples. Order Synthroid no prescription. Discount Lipitor.
Trackbacks from: Flagyl No Rx. Flagyl No Rx. Flagyl No Rx. Flagyl coupon. What is Flagyl. Is Flagyl safe.

[This review was originally posted at the Nieman Journalism Lab Synthroid For Sale, on Dec. 3, 2010.]

We're covering two weeks instead of the usual one in this review, so there's a ton to pack in here. I'll try to zip through it a little more quickly than usual.

What to make of WikiLeaks: WikiLeaks made its third big document drop since this summer this week, releasing about 250,000 confidential diplomatic cables. Here's coverage by The New York Times, Synthroid duration,  The Guardian, Der Spiegel, and a roundup by The Columbia Journalism Review. Time talked to WikiLeaks' Julian Assange about the leak, and Forbes published an interview and long piece about Assange's next target — corporate America, Synthroid For Sale.

As for the leak itself, The Guardian detailed the documents' path from the alleged leaker, U.S. soldier Bradley Manning, to Assange, to a Guardian reporter. Yahoo's Michael Calderone looked at The Times' editorial process with the cables, purchase Synthroid for sale, including the revelation that they got them from The Guardian, not WikiLeaks. The Wall Street Journal and CNN both declined to sign agreements with WikiLeaks to see the documents in advance, and The Journal examined news orgs' decisions on whether or not to publish. The Times explained its own publishing decision, then (quite eloquently) responded to readers' objections. Synthroid For Sale, The reaction against WikiLeaks was quicker and harsher than those following each of its last two leaks. Before the documents were released, its site was hacked, the U.S. Purchase Synthroid online no prescription, and British governments issued pre-emptive condemnations, and senators called for WikiLeaks to be prosecuted. After the release, the Obama administration said it was indeed pursuing a criminal investigation, Interpol revealed it has put out a call for Assange's arrest (ostensibly for his rape accusations), and Amazon booted WikiLeaks from its servers under pressure from U.S. Sen. Joe Lieberman, Synthroid For Sale.

WikiLeaks' actions left many journalists and media observers divided: An Economist blogger accused WikiLeaks of degenerating into gossip, and even Wikipedia co-founder Larry Sanger called them enemies of the American people. Assange and WikiLeaks had their defenders, purchase Synthroid, too: Slate's Jack Shafer praised them for puncturing "the prerogative of secrecy," and another Economist blogger made a similar argument. The Guardian's Simon Jenkins noted that "the job of the media is not to protect power from embarrassment." Meanwhile, Northeastern j-prof Dan Kennedy wrestled with the balance between transparency and secrecy.

Others' primary concern was not value judgments, but classification. Is WikiLeaks  Synthroid For Sale, espionage. Journalism? Radically open government? Or, as CUNY j-prof C.W. Purchase Synthroid online, Anderson argued, is it a facilitator of real-time history documentation. NYU j-prof Jay Rosen hashed out his thoughts on WikiLeaks as a stateless news organization on video, concluding, "The watchdog press died, and what we have is WikiLeaks instead." Paul Balcerak wondered why WikiLeaks gets so much more attention than the press's own reporting.

If you really want to spend the weekend pondering the meaning of WikiLeaks, it's best to start with two posts: Some incisive questions by Salon's Dan Gillmor, and a brilliant post by Aaron Bady sifting through Assange's own words to determine his motivations behind WikiLeaks' radical transparency.

—

Rupert's big tablet splash: We've heard bits and pieces about Rupert Murdoch's planned tablet-based national news publication, but we got the first substantive report on the subject two weeks ago from Women's Wear Daily, Synthroid For Sale. Among the key details: It's going by The Daily, Synthroid price, coupon, it has a staff of 100, it'll cost 99 cents a week, and it'll come out once a day. The New York Observer gave us some more information about the publication's design (it's text-first and will be published overnight, but apparently looks pretty cool). Other tidbits: John Gruber at Daring Fireball heard that it'll pioneer a new app subscription API from Apple, and New York's Gabriel Snyder said it will have a centrist editorial outlook.

The reasons why this project is getting so much pre-launch attention seem pretty readily evident: Murdoch, Synthroid mg, original tablet news org, iPad news subscriptions, you know the rest. As The Columbia Journalism Review noted Synthroid For Sale, , what's new about this publication is that it won't even have a website. The initial response from the media-watching world was predominantly negative, with skepticism coming from The New York Times' David Carr, Gawker's Ryan Tate, Scott Rosenberg, Sam Diaz of ZDNet, GigaOM's Mathew Ingram, Fast Company's Kit Eaton, comprar en línea Synthroid, comprar Synthroid baratos, The Guardian's Emily Bell, and paidContent's Andrew Wallenstein.

Many of those critics made similar points, so here's a roundup of the main ones: 1) It's trying to impose slow print-think onto the speed-oriented world of mobile media (this is Rosenberg's main point); 2) The fact that it won't have inbound or outbound links means it can't share in the virality that makes news on the Web work; 3) The folks on board don't exactly seem like the tech revolutionaries they might need to be (Wallenstein's main point); and 4) How many people are actually going to pay for this, and can it really cover The Daily's costs. (Carr's main objection)

Several of those people also noted a few factors in Murdoch's favor: Carr argued that people will be more likely to pay for news in an app world than on the web, and both Tate and Eaton noted that Apple's Steve Jobs (who is reported to be tied to the project) is a pretty powerful guy with a history of success in ventures like these. We got a few good suggestions for Murdoch's project, Doses Synthroid work, too: TechCrunch's Erick Schonfeld said to make it local, real-time, and social; Frederic Filloux wanted it speedy, simple, beyond Apple, and with adjustable pricing; and at paidContent, Nic Newman wanted to see a mixture of free and paid content.

—

Designing apps for tablets and mobile media: Murdoch isn't the only one with a big new tablet app to unveil: Yahoo's Joe Pompeo summarized two others — mini-magazines called Nomad Editions and a new iPad magazine by Virgin called Project, Synthroid For Sale. Of those, Project, announced Tuesday, ordering Synthroid online, got a bit more attention. PaidContent had some details about its video cover and "living magazine" mindset, and All Things Digital's Peter Kafka pointed out the magazine's rather intimidating instruction page, though David Carr told NPR it's still pretty magazine-like.

Also in the process of launching: Next Issue Media, a joint venture by several magazine magnates, will launch its digital newsstand early next year and gave some details to MediaWeek, and Swedish publisher Bonnier, Synthroid photos, whose Mag+ everyone loved, is expanding into News+. Meanwhile, the Financial Times' iPad app is doing well, but The Guardian's Dan Sabbagh remained skeptical that most newspapers' iPad apps will be able to stand out among the sea of more enjoyable apps.

A couple more smart thoughts on mobile media: PaidContent founder Rafat Ali talked about Synthroid For Sale, designing for touchscreens, and Poynter's Damon Kiesow argued that smartphones are fundamentally a mobile device, while the iPad is a leisure device, so their apps can't be imposed onto each other: "To fully serve and engage an audience, an app needs to target one distinctive strength — either location or leisure — and make the content and experience fit that use."

—

Gawker grows beyond the blog: In advance of its coming overhaul early next year, Gawker head Nick Denton wrote a manifesto explaining why the network of sites is going beyond the blog format (his post at the previous link is in the sites' new design). Denton said he's discovered the new formula for online media success: Not so much Gawker's former trademark snarky meta-analysis, but a few huge juicy scoops accompanied by a steady stream of aggregation, all with a visual bent. He extended the model to include advertising and branding as well.

Reuters' Felix Salmon responded with a meticulous analysis of Gawker's new direction, Synthroid description, noting that while Denton was the first person to make blogging into "a large-scale commercial venture," he's now aggressively dumping blogging's defining reverse-chronological format. Ron Mwangaguhunga of eMedia Vitals compared Gawker's new model with a TV business model, and Anil Dash said that while Gawker is still a blog, it's borrowing Twitter's design that emphasizes both content and the stream of news. "By allowing that flow to continue regardless of which particular piece of embedded content has caught your eye, Gawker and Twitter are just showing the vibrancy and resilience of the format."

—

Why Twitter matters: Speaking of Twitter, Guardian editor Alan Rusbridger offered a stirring defense of Twitter's meaning for journalism as part of a lecture on the state of the Fourth Estate. His list of 15 reasons Twitter matters covers most everything: Reporting, conversation, aggregation, search, marketing, authority, writing, Synthroid For Sale. Likewise, Synthroid street price, GigaOM's Mathew Ingram argued that Twitter's real cultural power "could well be that it is the simplest, the easiest and arguably one of the most efficient forms of mass publishing — or at least micro-publishing — ever invented."

Later, Ingram took Twitter co-founder Biz Stone's apparently off-the-cuff statement that Twitter could develop a news network as an opportunity to think about how news orgs could filter Twitter into a usable crowdsourced newswire. And MediaBistro talked with Canada's National Post to get a sense of how one major newspaper uses Twitter.

—

Business-model developments and discussion: A few notes on the ever-evolving paid-content front: At least two more news organizations are using the Press+ system of Steve Brill's Journalism Online for their online revenue goals — ProPublica, which is using it to solicit donations online, and Oklahoma State's Daily O'Collegian, which will charge outside-the-area readers. Over at The Guardian, Cory Doctorow examined The Times of London's paywall numbers, and CrunchGear's Devin Coldewey thought out loud about a possible online paid-content system, order Synthroid from United States pharmacy.

Meanwhile, British journalist Kevin Anderson wrote a post arguing that value-added journalism has to be developed with specific revenue streams in mind. Howard Owens of The Batavian countered Synthroid For Sale, that would-be entrepreneurial journalists need to focus more on basic local events journalism than "adding value" or analytical journalism, and TBD's Steve Buttry tried to bring the two perspectives together.

—

Reading roundup: Here's what else you should see this week, in the quickest-hit form I can give it to you:

— A British court upheld a stipulation that news organizations can charge paid online news monitoring agencies for using their content. The Telegraph, TechCrunch Europe, and the Press Gazette explain why it's bad news for aggregators.

— No less an authority than World Wide Web inventor Tim Berners-Lee joined the chorus of people extolling the value of data journalism during a panel. A somewhat related debate broke out when Mark Luckie opined on the myths about digital journalism skills. Discount Synthroid, Journalist Andy Boyle disputed Luckie's claims about what new-media skills journalists need (and don't need) to know, and j-prof Mindy McAdams and journalist Brian Manzullo chimed in. Anthony DeBarros and Robert Hernandez turned the discussion toward data journalism, with Hernandez asserting that programming doesn't replace the story. That got Michelle Minkoff kind of riled up, Synthroid For Sale.

— The New York Times ran an article looking at the ways technology is creating increased distractions for young people, which was met by smart rebuttals by Duke prof Cathy Davidson and the Lab's own Megan Garber.

— Also at the Lab: USC prof Henry Jenkins on his concept of "spreadable" media.

— Mashable's Vadim Lavrusik wrote a great roundup of what's going on at the intersection of investigative journalism and social media.

— Finally, if you're looking for a single document to answer the question, "How should newspapers adapt to this new media environment?" you can't do much better than John Paton's presentation on how he's turned around the Journal Register Co. It's brilliant.

Similar posts: Cipro Price. Armour Dosage. Purchase Synthroid. Japan, craiglist, ebay, overseas, paypal. Buy Glucophage from mexico. Flagyl without prescription.
Trackbacks from: Synthroid For Sale. Synthroid For Sale. Synthroid For Sale. Buy generic Synthroid. Synthroid australia, uk, us, usa. Get Synthroid.